2184. Effect of Adjusted CLSI Breakpoints on Center-wide Fluoroquinolone Susceptibilities for Enterobacteriaceae and Pseudomonas aeruginosa: Is It Time to Restrict Empiric Fluoroquinolone Use?

BACKGROUND: In January 2019, the Clinical and Laboratory Standards Institute (CLSI) lowered breakpoints of fluoroquinolones (FQ) for Enterobacteriaceae (EB)and Pseudomonas aeruginosa (PsAr). Automated commercial antimicrobial susceptibility testing (cAST) can only report levofloxacin MIC ≤1 μg/mL ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Sansom, Sarah, Moore, Nicholas M, Kazi, Aamir S, Won, Sarah Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810838/
http://dx.doi.org/10.1093/ofid/ofz360.1864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810838/
http://dx.doi.org/10.1093/ofid/ofz360.1864

Ejemplares similares